Biosignature Discovery for Personalized Treatment in Depression: On September 17, 2009 the U.S. Department of Health and Human Services National Institutes of Health announced the availability of funding for the Biosignature Discovery for Personalized Treatment in Depression Program (Catalog of Federal Domestic Assistance number 93.242). The purpose of this program is to support exploratory research to discover panels of promising potential biomarkers (i.e., biosignatures) that are predictive of treatment outcomes in major depressive disorder (MDD) and to establish a data resource for the genetic study of MDD. The application deadline is January 13, 2010.  Eligible applicants include state governments, institutions of higher education and nonprofit organizations. To request an application package, visit www.grants.gov. For further information, contact Benedetto Vitiello, M.D., Division of Services and Intervention Research, National Institute of Mental Health, 6001 Executive Boulevard, Bethesda, MD 20892-9633, (301) 443-3357, bvitiell@mail.nih.gov.